Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

N-Acetyl Cysteine and Reduced Exacerbation Frequency

Safety in these studies
1 of 1 paper
  • Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

    • 2026-04
    • Meta-Analysis · n = 7,051
    • European respiratory review : an official journal of the European Respiratory Society 35(180)
      • Benjamin McCullough
      • John Busby
      • Brenda O'Neill
      • Bronwen Connolly
      • Rebecca H McLeese
      • Dermot Linden
      • Daniel F McAuley
      • J Stuart Elborn
      • Anthony De Soyza
      • James D Chalmers
      • Mike Clarke
      • Judy M Bradley
    • High evidence
    • Clinical

    Seven randomised studies (n=1259) reported exacerbations; pooled analysis did not demonstrate a statistically significant difference in annualised exacerbation incidence (mean difference -0.40 per patient per year, 95% CI -1.04-0.24; p=0.22; I²=91%; very low certainty).

    Effect
    Neutral
    Effect size
    Small
    Significant
    No
Back to top